TP53 and colorectal carcinoma: These data verify the specificity of CPI‐1612, which equally suppressed the accumulation of acK382‐p53 in irinotecan plus entinostat‐treated RKO, HROC24, and HHC6548 CRC cells (Fig. S8A,B).